# US 2025/0214939 A1 · Method for treating inflammation and hypertension with gamma-ketoaldehyde skavengers

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0214939 A1
- Document ID: US20250214939A1
- Status: Published application
- Kind: A1
- Application number: 18/917,789
- Filed: 2024-10-16
- Published: 2025-07-03
- Earliest claimed: 2011-07-12
- Assignees: Vanderbilt University
- Applicants: Vanderbilt University
- Inventors: L. Jackson Roberts, II; Venkataraman Amarnath; David G. Harrison; Annet Kirabo
- Web page: https://patentgrep.com/patent/US20250214939A1

## CPC

- C07D 213/65: attached in position 3 or 5
- A61K 31/137: Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine {or methadone}
- A61K 31/44: Non condensed pyridines; Hydrogenated derivatives thereof
- A61P 9/12: Antihypertensives
- A61P 17/06: Antipsoriatics
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 37/02: Immunomodulators
- C07C 215/50: with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
- C07C 217/58: with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

A method of treating or ameliorating an inflammatory autoimmune response, comprising administering to a patient in need there of an effective gamma-ketoaldehyde scavenging amount of a gamma-ketoaldehyde scavenging compound.

## Claims

### Claim 1

A method of treating or ameliorating an inflammatory autoimmune response, comprising administering to a patient in need thereof a compound of the following formula:
wherein:
R is C;
R2 is H;
R3 is H or C1-6 alkyl;
R4 is H;
R5 is H or C1-6 alkyl;
or a pharmaceutically acceptable salt thereof.

### Claim 2 (depends on 1)

The method of claim 1, wherein the compound is 2-hydroxybenzylamine, methyl-2-hydroxybenzylamine, or ethyl-2-hydroxybenzylamine.

### Claim 3 (depends on 1)

The method of claim 1, wherein the compound is of the following formula:
or a pharmaceutically acceptable salt thereof.

### Claim 4 (depends on 1)

The method of claim 1, wherein the inflammatory response is in connection with Crohn's disease, inflammatory bowel disease, and ulcerative colitis, asthma, graft versus host disease, chronic obstructive pulmonary disease; Graves' disease, rheumatoid arthritis.

### Claim 5 (depends on 1)

The method of claim 1, wherein the inflammatory response is in connection with Rheumatoid arthritis, osteoarthritis, inflammatory arthropathies, acute gout, dysmenorrhoea, metastatic bone pain, headache and migraine, postoperative pain, mild-to-moderate pain due to inflammation and tissue injury, pyrexia, ileus, and renal colic.

### Claim 6 (depends on 1)

The method of claim 1, wherein the patient is in need treatment for (a) reducing inflammation, pain or fever; (b) treating a gastrointestinal disorder; (c) facilitating wound healing; (d) treating or reversing gastrointestinal, renal and/or respiratory toxicity; (e) treating an inflammatory disease, (f) reducing hypertension, and/or (f) treating an ophthalmic disorder in a patient in need thereof.

### Claim 7 (depends on 1)

The method of claim 1, wherein the gastrointestinal disorder is an inflammatory bowel disease, Crohn's disease, gastritis, irritable bowel syndrome, constipation, ulcerative colitis, a peptic ulcer, a stress ulcer, a bleeding ulcer, gastric hyperacidity, dyspepsia, gastroparesis, Zollinger-Ellison syndrome, gastroesophageal reflux disease, a bacterial infection, short-bowel (anastomosis) syndrome, or a hypersecretory state associated with systemic mastocytosis or basophilic leukemia and hyperhistaminemia.

### Claim 8 (depends on 6)

The method of claim 6, wherein the wound may be an ulcer.

### Claim 9 (depends on 6)

The method of claim 6, where the inflammatory disease may be a cardiovascular disorder, reperfusion injury to an ischemic organ, angiogenisis, arthritis, asthma, bronchitis, premature labor, tendinitis, bursitis, an autoimmune disease, an immunological disorder, a skin-related condition, neoplasia, an inflammatory process in a disease, pulmonary inflammation, a central nervous system disorder, allergic rhinitis, respiratory distress syndrome, endotoxin shock syndrome, a microbial infection, a bacterial-induced inflammation, a viral induced inflammation, a urinary disorder, a urological disorder, endothelial dysfunction, organ deterioration, tissue deterioration, a sexual dysfunction or activation, adhesion and infiltration of neutrophils at the site of inflammation.
